本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Standard BioTools Inc.

1.35
-0.0200-1.46%
盘后1.350.00000.00%16:13 EDT
成交量:86.04万
成交额:115.04万
市值:5.13亿
市盈率:-3.81
高:1.39
开:1.38
低:1.31
收:1.37
数据加载中...
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/01/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans